Wave Life Sciences
49 hedge funds and large institutions have $432M invested in Wave Life Sciences in 2017 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 19 increasing their positions, 13 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
49
Holders Change
-2
Holders Change %
-3.92%
% of All Funds
1.22%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
7
Increased
19
Reduced
13
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$9.46M |
| 2 |
BlackRock
New York
|
+$9.24M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
+$8.78M |
| 4 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
+$5.28M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$2.15M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.7M |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$780K |
| 3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$710K |
| 4 |
Renaissance Technologies
New York
|
-$403K |
| 5 |
Morgan Stanley
New York
|
-$313K |
